Synapses compute and transmit information to connect neural circuits and are at the basis of brain operations. Alterations in their function contribute to a vast range of neuropsychiatric and neurodegenerative disorders and synapse-based therapeutic intervention, such as selective inhibition of synaptic transmission, may significantly help against serious pathologies. Graphene is a two-dimensional nanomaterial largely exploited in multiple domains of science and technology, including biomedical applications. In hippocampal neurons in culture, small graphene oxide nanosheets (s-GO) selectively depress glutamatergic activity without altering cell viability. Glutamate is the main excitatory neurotransmitter in the central nervous system and growing evidence suggests its involvement in neuropsychiatric disorders. Here we demonstrate that s-GO directly targets the release of presynaptic vesicle. We propose that s-GO flakes reduce the availability of transmitter, via promoting its fast release and subsequent depletion, leading to a decline ofglutamatergic neurotransmission. We injected s-GO in the hippocampus in vivo, and 48 h after surgery ex vivo patch-clamp recordings from brain slices show a significant reduction in glutamatergic synaptic activity in respect to saline injections.

Graphene oxide flakes tune excitatory neurotransmission in vivo by targeting hippocampal synapses / Rauti, Rossana; Medelin, Manuela; Newman, Leon; Vranic, Sandra; Reina, Giacomo; Bianco, Alberto; Prato, Maurizio; Kostarelos, Kostas; Ballerini, Laura. - In: NANO LETTERS. - ISSN 1530-6984. - 19:5(2019), pp. 2858-2870. [10.1021/acs.nanolett.8b04903]

Graphene oxide flakes tune excitatory neurotransmission in vivo by targeting hippocampal synapses

Rauti, Rossana
Investigation
;
Medelin, Manuela
Membro del Collaboration group
;
Ballerini, Laura
Conceptualization
2019-01-01

Abstract

Synapses compute and transmit information to connect neural circuits and are at the basis of brain operations. Alterations in their function contribute to a vast range of neuropsychiatric and neurodegenerative disorders and synapse-based therapeutic intervention, such as selective inhibition of synaptic transmission, may significantly help against serious pathologies. Graphene is a two-dimensional nanomaterial largely exploited in multiple domains of science and technology, including biomedical applications. In hippocampal neurons in culture, small graphene oxide nanosheets (s-GO) selectively depress glutamatergic activity without altering cell viability. Glutamate is the main excitatory neurotransmitter in the central nervous system and growing evidence suggests its involvement in neuropsychiatric disorders. Here we demonstrate that s-GO directly targets the release of presynaptic vesicle. We propose that s-GO flakes reduce the availability of transmitter, via promoting its fast release and subsequent depletion, leading to a decline ofglutamatergic neurotransmission. We injected s-GO in the hippocampus in vivo, and 48 h after surgery ex vivo patch-clamp recordings from brain slices show a significant reduction in glutamatergic synaptic activity in respect to saline injections.
2019
19
5
2858
2870
https://doi.org/10.1021/acs.nanolett.8b04903
https://pubs.acs.org/doi/10.1021/acs.nanolett.8b04903#
Rauti, Rossana; Medelin, Manuela; Newman, Leon; Vranic, Sandra; Reina, Giacomo; Bianco, Alberto; Prato, Maurizio; Kostarelos, Kostas; Ballerini, Laura...espandi
File in questo prodotto:
File Dimensione Formato  
nl-2018-04903j _R2_main text.pdf

accesso aperto

Tipologia: Documento in Pre-print
Licenza: Non specificato
Dimensione 874 kB
Formato Adobe PDF
874 kB Adobe PDF Visualizza/Apri
nl-2018-04903j _R2_Supporting Information.pdf

accesso aperto

Tipologia: Altro materiale allegato
Licenza: Non specificato
Dimensione 441.63 kB
Formato Adobe PDF
441.63 kB Adobe PDF Visualizza/Apri
acs.nanolett.8b04903.pdf

non disponibili

Tipologia: Versione Editoriale (PDF)
Licenza: Non specificato
Dimensione 6.95 MB
Formato Adobe PDF
6.95 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11767/89920
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 45
  • ???jsp.display-item.citation.isi??? 43
social impact